Highly specific PET imaging of prostate tumors in mice with an iodine-124-labeled antibody fragment that targets phosphatidylserine

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Stafford, Jason H ^a   Hao, Guiyang ^b   Best, Anne M ^a   Sun, Xiankai ^b   Thorpe, Philip E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; DOCETAXEL; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IODINE 124; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PGN635; MONOCLONAL ANTIBODY PGN635 IMMUNOGLOBULIN F(AB')2 FRAGMENT I 124; PGN 635; PHOSPHATIDYLSERINE; PLACEBO; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; DRUG BINDING; DRUG DISTRIBUTION; DRUG RESPONSE; DRUG STABILITY; DRUG TARGETING; DRUG TUMOR LEVEL; IMAGE ANALYSIS; ISOTOPE LABELING; KIDNEY; LIVER; MALE; MOUSE; MOUSE MODEL; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER; TISSUE DISTRIBUTION; TREATMENT RESPONSE; TUMOR LOCALIZATION;

ANIMALS; BETA 2-GLYCOPROTEIN I; IMMUNOGLOBULIN FAB FRAGMENTS; IODINE RADIOISOTOPES; MALE; MICE; MICE, NUDE; PHOSPHATIDYLSERINES; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; TAXOIDS;

EID: 84893198158     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084864     Document Type: Article

References (50)

1. Williamson P, Schlegel RA (1994) Back and forth: the regulation and function of transbilayer phospholipid movement in eukaryotic cells. Mol Membr Biol 11: 199-216. doi:10.3109/09687689409160430. PubMed: 7711830.
2. Marconescu A, Thorpe PE (2008) Coincident exposure of phosphatidylethanolamine and anionic phospholipids on the surface of irradiated cells. Biochim Biophys Acta 1778: 2217-2224. doi:10.1016/j.bbamem.2008.05.006. PubMed: 18570887.
3. Bitbol M, Fellmann P, Zachowski A, Devaux PF (1987) Ion regulation of phosphatidylserine and phosphatidylethanolamine outside-inside translocation in human erythrocytes. Biochim Biophys Acta 904: 268-282. doi:10.1016/0005-2736(87) 90376-2. PubMed: 3117114.
4. Balasubramanian K, Mirnikjoo B, Schroit AJ (2007) Regulated externalization of phosphatidylserine at the cell surface: implications for apoptosis. J Biol Chem 282: 18357-18364. doi:10.1074/jbc.M700202200. PubMed: 17470427.
5. Storz P (2005) Reactive oxygen species in tumor progression. Front Biosci 10: 1881-1896. doi:10.2741/1667. PubMed: 15769673.
6. Ran S, Downes A, Thorpe PE (2002) Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res 62: 6132-6140. PubMed: 12414638.
7. Zulueta JJ, Yu FS, Hertig IA, Thannickal VJ, Hassoun PM (1995) Release of hydrogen peroxide in response to hypoxia-reoxygenation: role of an NAD(P)H oxidase-like enzyme in endothelial cell plasma membrane. Am J Respir Cell Mol Biol 12: 41-49. doi:10.1165/ajrcmb.12.1.7529030. PubMed: 7529030.
8. Huang X, Bennett M, Thorpe PE (2005) A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice. Cancer Res 65: 4408-4416. doi:10.1158/0008-5472.CAN-05-0031. PubMed: 15899833.
9. He J, Luster TA, Thorpe PE (2007) Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids. Clin Cancer Res 13: 5211-5218. doi:10.1158/1078-0432.CCR-07-0793. PubMed: 17785577.
10. He J, Yin Y, Luster TA, Watkins L, Thorpe PE (2009) Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma. Clin Cancer Res 15: 6871-6880. doi:10.1158/1078-0432.CCR-09-1499. PubMed: 19887482.
11. Stafford JH, Thorpe PE (2011) Increased exposure of phosphatidylethanolamine on the surface of tumor vascular endothelium. Neoplasia 13: 299-308. PubMed: 21472134.
12. Kartachova M, van Zandwijk N, Burgers S, van Tinteren H, Verheij M et al. (2007) Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. J Clin Oncol 25: 2534-2539. doi:10.1200/JCO.2006.10.1337. PubMed: 17577031.
13. Bauwens M, De Saint-Hubert M, Devos E, Deckers N, Reutelingsperger C et al. (2011) Site-specific (68)Ga-labeled Annexin A5 as a PET imaging agent for apoptosis. Nucl Med Biol 38: 381-392. doi:10.1016/j.nucmedbio.2010.09.008. PubMed: 21492787.
14. Collingridge DR, Glaser M, Osman S, Barthel H, Hutchinson OC et al. (2003) In vitro selectivity, in vivo biodistribution and tumour uptake of annexin V radiolabelled with a positron emitting radioisotope. Br J Cancer 89: 1327-1333. doi:10.1038/sj.bjc.6601262. PubMed: 14520468.
15. Yagle KJ, Eary JF, Tait JF, Grierson JR, Link JM et al. (2005) Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis. J Nucl Med 46: 658-666. PubMed: 15809489.
16. Loose D, Vermeersch H, De Vos F, Deron P, Slegers G et al. (2008) Prognostic value of 99mTc-HYNIC annexin-V imaging in squamous cell carcinoma of the head and neck. Eur J Nucl Med Mol Imaging 35: 47-52. doi:10.1007/s00259-007- 0577-0. PubMed: 17906858.
17. Belhocine T, Steinmetz N, Hustinx R, Bartsch P, Jerusalem G et al. (2002) Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin Cancer Res 8: 2766-2774. PubMed: 12231515.
18. Wang F, Fang W, Zhao M, Wang Z, Ji S et al. (2008) Imaging paclitaxel (chemotherapy)-induced tumor apoptosis with 99mTc C2A, a domain of synaptotagmin I: a preliminary study. Nucl Med Biol 35: 359-364. doi:10.1016/j.nucmedbio. 2007.12.007. PubMed: 18355692.
19. Wang F, Fang W, Zhang MR, Zhao M, Liu B et al. (2011) Evaluation of Chemotherapy Response in VX2 Rabbit Lung Cancer with 18F-Labeled C2A Domain of Synaptotagmin I. J Nucl Med 52: 592-599. doi:10.2967/jnumed.110.081588. PubMed: 21421722.
20. Smith BA, Akers WJ, Leevy WM, Lampkins AJ, Xiao S et al. (2010) Optical imaging of mammary and prostate tumors in living animals using a synthetic near infrared zinc(II)-dipicolylamine probe for anionic cell surfaces. J Am Chem Soc 132: 67-69. doi:10.1021/ja908467y. PubMed: 20014845.
21. Luster TA, He J, Huang X, Maiti SN, Schroit AJ et al. (2006) Plasma protein beta-2-glycoprotein 1 mediates interaction between the antitumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells. J Biol Chem 281: 29863-29871. doi:10.1074/jbc.M605252200. PubMed: 16905548.
22. Jennewein M, Lewis MA, Zhao D, Tsyganov E, Slavine N et al. (2008) Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine. Clin Cancer Res 14: 1377-1385. doi:10.1158/1078-0432.CCR-07-1516. PubMed: 18316558.
23. Divgi CR, Pandit-Taskar N, Jungbluth AA, Reuter VE, Gonen M, et al. (2007) Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial. Lancet Oncol 8: 304-310.
24. Carrasquillo JA, Pandit-Taskar N, O'Donoghue JA, Humm JL, Zanzonico P et al. (2011) (124)I-huA33 antibody PET of colorectal cancer. J Nucl Med 52: 1173-1180. doi:10.2967/jnumed.110.086165. PubMed: 21764796.
25. Wu AM (2009) Antibodies and antimatter: the resurgence of immuno-PET. J Nucl Med 50: 2-5. PubMed: 19091888.
26. Wall JS, Kennel SJ, Paulus M, Gregor J, Richey T et al. (2006) Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody. J Nucl Med 47: 2016-2024. PubMed: 17138745.
27. Orlova A, Wållberg H, Stone-Elander S, Tolmachev V (2009) On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model. J Nucl Med 50: 417-425. doi:10.2967/jnumed.108.057919. PubMed: 19223403.
28. Alhasan MK, Liu L, Lewis MA, Magnusson J, Mason RP (2012) Comparison of Optical and Power Doppler Ultrasound Imaging for Non-Invasive Evaluation of Arsenic Trioxide as a Vascular Disrupting Agent in Tumors. PLOS ONE 7: e46106. doi:10.1371/journal.pone.0046106. PubMed: 23029403.
29. Schwarzenbacher R, Zeth K, Diederichs K, Gries A, Kostner GM et al. (1999) Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J 18: 6228-6239. doi:10.1093/emboj/18.22.6228. PubMed: 10562535.
30. Kolesnick RN, Krönke M (1998) Regulation of ceramide production and apoptosis. Annu Rev Physiol 60: 643-665. doi:10.1146/annurev.physiol.60.1.643. PubMed: 9558480.
31. Mathias S, Peña LA, Kolesnick RN (1998) Signal transduction of stress via ceramide. Biochem J 335 (3): 465-480. PubMed: 9794783.
32. Ogasawara A, Tinianow JN, Vanderbilt AN, Gill HS, Yee S et al. (2013) ImmunoPET imaging of phosphatidylserine in pro-apoptotic therapy treated tumor models. Nucl Med Biol, 40: 15-22. PubMed: 23062948.
33. Wahl RL, Parker CW, Philpott GW (1983) Improved radioimaging and tumor localization with monoclonal F(ab′)2. J Nucl Med 24: 316-325. PubMed: 6339689.
34. Covell DG, Barbet J, Holton OD, Black CD, Parker RJ et al. (1986) Pharmacokinetics of monoclonal immunoglobulin G1, F(ab′)2, and Fab′ in mice. Cancer Res 46: 3969-3978. PubMed: 3731067.
35. Boswell CA, Sun X, Niu W, Weisman GR, Wong EH et al. (2004) Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. J Med Chem 47: 1465-1474. doi:10.1021/jm030383m. PubMed: 14998334.
36. Zhao D, Stafford JH, Zhou H, Thorpe PE (2011) Near-infrared Optical Imaging of Exposed Phosphatidylserine in a Mouse Glioma Model. Transl Oncol 4: 355-364. PubMed: 22191000.
37. Czernin J, Schelbert H (2004) PET/CT Imaging: Facts, Opinions, Hopes, and Questions. Journal of Nuclear Medicine 45: 1S-3S.
38. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE et al. (2001) A tabulated summary of the FDG PET literature. J Nucl Med 42: 1S-93S. PubMed: 11483694.
39. Emonds KM, Swinnen JV, Mortelmans L, Mottaghy FM (2009) Molecular imaging of prostate cancer. Methods 48: 193-199. doi:10.1016/j.ymeth.2009.03.021. PubMed: 19362147.
40. Pentlow KS, Graham MC, Lambrecht RM, Daghighian F, Bacharach SL et al. (1996) Quantitative imaging of iodine-124 with PET. J Nucl Med 37: 1557-1562. PubMed: 8790218.
41. Belov VV, Bonab AA, Fischman AJ, Heartlein M, Calias P et al. (2011) Iodine-124 as a Label for Pharmacological PET Imaging. Mol Pharm 8: 736-747. doi:10.1021/mp100358f. PubMed: 21361362.
42. Blankenberg F (2002) To scan or not to scan, it is a question of timing: technetium-99m-annexin V radionuclide imaging assessment of treatment efficacy after one course of chemotherapy. Clin Cancer Res 8: 2757-2758. PubMed: 12231512.
43. Kemerink GJ, Liu X, Kieffer D, Ceyssens S, Mortelmans L et al. (2003) Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application. J Nucl Med 44: 947-952. PubMed: 12791824.
44. Vanderheyden JL, Liu G, He J, Patel B, Tait JF et al. (2006) Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice. Nucl Med Biol 33: 135-144. doi:10.1016/j.nucmedbio.2005.09. 002. PubMed: 16459269.
45. Verroust PJ, Birn H, Nielsen R, Kozyraki R, Christensen EI (2002) The tandem endocytic receptors megalin and cubilin are important proteins in renal pathology. Kidney Int 62: 745-756. doi:10.1046/j.1523-1755.2002.00501.x. PubMed: 12164855.
46. Klaassen CD, Aleksunes LM (2010) Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 62: 1-96. doi:10.1124/pr.109.002014. PubMed: 20103563.
47. Capila I, Hernáiz MJ, Mo YD, Mealy TR, Campos B et al. (2001) Annexin V - heparin oligosaccharide complex suggests heparan sulfate - mediated assembly on cell surfaces. Structure 9: 57-64. doi:10.1016/S0969-2126(00)00549- 9. PubMed: 11342135.
48. Riedl S, Rinner B, Asslaber M, Schaider H, Walzer S et al. (2011) In search of a novel target - phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy. Biochim Biophys Acta 1808: 2638-2645. doi:10.1016/j.bbamem.2011.07.026. PubMed: 21810406.
49. Belhocine T, Steinmetz N, Green A, Rigo P (2003) In vivo imaging of chemotherapy-induced apoptosis in human cancers. Ann N Y Acad Sci 1010: 525-529. doi:10.1196/annals.1299.097. PubMed: 15033784.
50. Hoebers FJ, Kartachova M, de Bois J, van den Brekel MW, van Tinteren H et al. (2008) 99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging 35: 509-518. doi:10.1007/s00259-007-0624-x. PubMed: 17994297.